Identification of 2-Amino Benzothiazoles with Bactericidal Activity against Mycobacterium tuberculosis

被引:1
|
作者
Bonnett, Shilah [1 ]
Jee, Jo-Ann [1 ]
Chettiar, Somsundaram [1 ]
Ovechkina, Yulia [1 ]
Korkegian, Aaron [1 ]
Greve, Eric [2 ]
Odingo, Joshua [1 ]
Parish, Tanya [1 ,2 ]
机构
[1] TB Discovery Res Infect Dis Res Inst, Seattle, WA 98102 USA
[2] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98105 USA
来源
MICROBIOLOGY SPECTRUM | 2023年 / 11卷 / 01期
基金
美国国家卫生研究院;
关键词
antitubercular; drug discovery; antibiotic; protein secretion; bactericidal activity; tuberculosis; DRUGS;
D O I
10.1128/spectrum.04974-22
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Mycobacterium tuberculosis, the causative agent of tuberculosis, is a serious global health problem requiring the development of new therapeutics. We previously ran a high-throughput screen and identified a series of compounds with antitubercular activity. We identified an amino-benzothiazole scaffold from a whole-cell screen against recombinant Mycobacterium tuberculosis under expressing the essential signal peptidase LepB. The seed molecule had 2-fold higher activity against the LepB hypomorph. Through a combination of purchase and chemical synthesis, we explored the structure-activity relationship for this series; 34 analogs were tested for antitubercular activity and for cytotoxicity against eukaryotic cells. We identified molecules with improved potency and reduced cytotoxicity. However, molecules did not appear to target LepB directly and did not inhibit protein secretion. Key compounds showed good permeability, low protein binding, and lack of CYP inhibition, but metabolic stability was poor with short half-lives. The seed molecule showed good bactericidal activity against both replicating and nonreplicating bacteria, as well as potency against intracellular M. tuberculosis in murine macrophages. Overall, the microbiological properties of the series are attractive if metabolic stability can be improved, and identification of the target could assist in the development of this series.IMPORTANCE Mycobacterium tuberculosis, the causative agent of tuberculosis, is a serious global health problem requiring the development of new therapeutics. We previously ran a high-throughput screen and identified a series of compounds with antitubercular activity. In this paper, we test analogs of our hit molecules for activity against M. tuberculosis, as well as for activity against eukaryotic cells. We identified molecules with improved selectivity. Our molecules killed both replicating and nonreplicating bacteria but did not work by targeting protein secretion.
引用
收藏
页数:17
相关论文
共 50 条
  • [11] Bactericidal effect of silver nanoparticles against Mycobacterium tuberculosis
    Praba, V. Lakshmi
    Kathirvel, M.
    Vallayyachari, K.
    Surendar, K.
    Muthuraj, M.
    Jesuraj, P. Justin
    Govindarajan, S.
    Raman, K.V.
    Journal of Bionanoscience, 2013, 7 (03): : 282 - 287
  • [12] Enniatin A1, A Natural Compound with Bactericidal Activity against Mycobacterium tuberculosis In Vitro
    Wang, Gaoyan
    Dong, Wenqi
    Lu, Hao
    Lu, Wenjia
    Feng, Jiajia
    Wang, Xiangru
    Chen, Huanchun
    Liu, Manli
    Tan, Chen
    MOLECULES, 2020, 25 (01):
  • [13] Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental model
    Cremades, Rosa
    Carlos Rodriguez, Juan
    Garcia-Pachon, Eduardo
    Galiana, Antonio
    Ruiz-Garcia, Montserrat
    Lopez, Pilar
    Royo, Gloria
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (10) : 2281 - 2283
  • [14] Bactericidal activity of OPC-67683 against drug-tolerant Mycobacterium tuberculosis
    Saliu, Oluwabunmi Y.
    Crismale, Catina
    Schwander, Stephan K.
    Wallis, Robert S.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (05) : 994 - 998
  • [15] Combinations of Respiratory Chain Inhibitors Have Enhanced Bactericidal Activity against Mycobacterium tuberculosis
    Berube, Bryan J.
    Parish, Tanya
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (01)
  • [16] Identification of new diamine scaffolds with activity against Mycobacterium tuberculosis
    Bogatcheva, Elena
    Hanrahan, Colleen
    Nikonenko, Boris
    Samala, Rowena
    Chen, Ping
    Gearhart, Jacqueline
    Barbosa, Francis
    Einck, Leo
    Nacy, Carol A.
    Protopopova, Marina
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (11) : 3045 - 3048
  • [17] POWERFUL BACTERICIDAL ACTIVITY OF SPARFLOXACIN (AT-4140) AGAINST MYCOBACTERIUM-TUBERCULOSIS IN MICE
    LALANDE, V
    TRUFFOTPERNOT, C
    PACCALYMOULIN, A
    GROSSET, J
    JI, BH
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (03) : 407 - 413
  • [18] 2-Phenylindole and Arylsulphonamide: Novel Scaffolds Bactericidal against Mycobacterium tuberculosis
    Naik, Maruti
    Ghorpade, Sandeep
    Jena, Lalit Kumar
    Gorai, Gopinath
    Narayan, Ashwini
    Guptha, Supreeth
    Sharma, Sreevalli
    Dinesh, Neela
    Kaur, Parvinder
    Nandishaiah, Radha
    Bhat, Jyothi
    Balakrishnan, Gayathri
    Humnabadkar, Vaishali
    Ramachandran, Vasanthi
    Naviri, Lava Kumar
    Khadtare, Pallavi
    Panda, Manoranjan
    Iyer, Pravin S.
    Chatterji, Monalisa
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (09): : 1005 - 1009
  • [19] A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis
    Kari A Sweeney
    Dee N Dao
    Michael F Goldberg
    Tsungda Hsu
    Manjunatha M Venkataswamy
    Marcela Henao-Tamayo
    Diane Ordway
    Rani S Sellers
    Paras Jain
    Bing Chen
    Mei Chen
    John Kim
    Regy Lukose
    John Chan
    Ian M Orme
    Steven A Porcelli
    William R Jacobs
    Nature Medicine, 2011, 17 : 1261 - 1268
  • [20] A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis
    Sweeney, Kari A.
    Dao, Dee N.
    Goldberg, Michael F.
    Hsu, Tsungda
    Venkataswamy, Manjunatha M.
    Henao-Tamayo, Marcela
    Ordway, Diane
    Sellers, Rani S.
    Jain, Paras
    Chen, Bing
    Chen, Mei
    Kim, John
    Lukose, Regy
    Chan, John
    Orme, Ian M.
    Porcelli, Steven A.
    Jacobs, William R., Jr.
    NATURE MEDICINE, 2011, 17 (10) : 1261 - U292